DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Requip (Ropinirole Hydrochloride) - Current Clinical Trials

 
 



Requip Related Clinical Trials

REQUIP RLS Post Marketing Surveillance [Completed]

Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets [Completed]

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions [Completed]

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions [Completed]

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 [Completed]

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease [Completed]

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's [Completed]

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition [Completed]

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition [Completed]

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo [Completed]

Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily [Completed]

Pramipexole Conversion to Ropinirole Controlled Release (CR) [Completed]

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's [Completed]

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients. [Completed]

Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 [Completed]

REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study [Completed]

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole [Completed]

Ropinirole Tablets In Young Patients With Restless Legs Syndrome [Completed]

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) [Completed]

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome [Completed]

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa [Completed]

Long-term Study Of Ropinirole In Restless Legs Syndrome [Completed]

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome [Completed]

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food [Completed]

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole [Completed]

Ropinirole in the Treatment of Bipolar Depression [Recruiting]

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients [Completed]

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease [Completed]

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome [Completed]

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome [Completed]

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients [Completed]

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome [Completed]

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole [Completed]

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease [Recruiting]

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) [Completed]

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease [Completed]

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) [Terminated]

Ropinirole 0.25 mg Tablets Under Fasting Conditions [Completed]

The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions [Completed]

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome [Completed]

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) [Completed]

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects [Completed]

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Recruiting]

Cognitive Remediation for Cocaine Dependence [Recruiting]

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type [Enrolling by invitation]

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions [Completed]

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions [Completed]

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression [Completed]

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine [Completed]

Fibromyalgia Study In Adults [Completed]

Trial of Ropinirole in Motor Recovery After Stroke [Completed]

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole [Completed]

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease [Completed]

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa [Completed]

Influence of Piribedil (ClariumŪ) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists [Completed]

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease [Completed]

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [Completed]

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease [Completed]

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) [Completed]

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease [Completed]

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease [Completed]

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome [Completed]

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist [Completed]

Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease [Terminated]

Butrans for Treatment of Restless Legs Syndrome [Withdrawn]

Naltrexone for Impulse Control Disorders in Parkinson's Disease [Completed]

Infusion of Apomorphine: Long-term Safety Study [Recruiting]

Study to Observe the Effect of Mirapex ERŪ Once-daily (QD) Versus Twice-daily (BID) [Recruiting]

ACP-103 to Treat Parkinson's Disease [Completed]

Talampanel to Treat Parkinson's Disease [Completed]

Levetiracetam Treatment of L-Dopa Induced Dyskinesias [Completed]

JP-1730 to Treat Parkinson's Disease [Completed]

Pergolide Treatment and Valvular Heart Disease [Completed]

Impact of Switching to Continuous Release Dopamine Agonists [Completed]

50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease [Completed]

Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD) [Completed]

Switching From Oral Dopamine Agonists to Rotigotine [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015